Search - tctmd.com

Displaying 101 - 120 of 144

Sort: Relevancy | Date

Presentation ACC 2021

Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction

Presenter: Deepak L. Bhatt

May 17, 2021

Presentation ACC 2021

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Adam DeVore

May 17, 2021

Presentation TCT 2020

TCT 637: Impella-Supported Directional Coronary Atherectomy in High Risk Patients With Reduced Left Ventricular Ejection Fraction

Presenter: Masaru Ishida

October 14, 2020

Presentation TCT 2020

TCT 134: Relative Quality of Life Improvement After Transcatheter Aortic Valve Replacement (TAVR) in Patients With Reduced Ejection Fraction.

Presenter: Hamza Lodhi

October 14, 2020

Presentation TCT 2020

TCT 421: Clinical Outcomes of Catheter-Guided Renal Denervation for the Treatment of Heart Failure With Reduced Ejection Fraction

Presenter: Daniel Garcia

October 14, 2020

Presentation TCT 2020

TCT 422: Effect of Sympathetic Renal Denervation on Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

Presenter: Syed Mustafa

October 14, 2020

Presentation TCT Abstracts Posters 2019

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Presenter: Cecillia Y Wong

October 28, 2019

Presentation TCT 2019

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Presenter: Joost Daemen

September 27, 2019

Presentation TCT 2019

Hong Kong Presents: TAVR in a Patient With Very Low Ejection Fraction

Presenter: Kam-Tim Chan

September 26, 2019

Presentation TCT 2019

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

Presenter: Ehtisham Mahmud

September 26, 2019

$Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction Primary results of the PARAGON-HF trial$

Presentation ESC 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

Presenter: Scott D. Solomon

September 01, 2019

Presentation CIT 2019

PCI for Patients with Very Low EF

Presenter: Ron Waksman

March 28, 2019

Presentation TCT Abstracts Posters 2018

Coronary Artery Calcium in Heart Failure with Preserved Ejection Fraction Patients: More Serious Than We Think

Presenter: Abdalla Hassan

September 25, 2018

Presentation TCT 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Presenter: Allan Schwartz, Stephan Windecker, Joost Daemen

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Presenter: Mackram F. Eleid

October 30, 2017

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

Presentation AHA 2016

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Presenter: David M Kaye

November 15, 2016

Presentation TCT 2016

Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction

Presenter: Daniel Burkhoff, Ileana L. Pina, Samuel J. Asirvatham

October 30, 2016

Advertisement

Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

TCT 637: Impella-Supported Directional Coronary Atherectomy in High Risk Patients With Reduced Left Ventricular Ejection Fraction

TCT 134: Relative Quality of Life Improvement After Transcatheter Aortic Valve Replacement (TAVR) in Patients With Reduced Ejection Fraction.

TCT 421: Clinical Outcomes of Catheter-Guided Renal Denervation for the Treatment of Heart Failure With Reduced Ejection Fraction

TCT 422: Effect of Sympathetic Renal Denervation on Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Hong Kong Presents: TAVR in a Patient With Very Low Ejection Fraction

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

PCI for Patients with Very Low EF

Coronary Artery Calcium in Heart Failure with Preserved Ejection Fraction Patients: More Serious Than We Think

Status Update of the TAVR UNLOAD Trial Moderate AS Patients with Reduced Ejection Fraction and Heart Failure

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

New Targets: Heart Failure With Preserved Ejection Fraction

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content